Physician profile
Michael Petelis
NPI 1699861237
$6,800.69
in general payments reported to CMS, 2019-2025
34 companies · $1,526 in 2025
The $1,526 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $727 · 2020: $522 · 2021: $1,264 · 2022: $822 · 2023: $772 · 2024: $1,169 · 2025: $1,526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,466.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,366.81 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $733.86 | 2021-2024 | |
| Amgen INC. | $552.54 | 2019-2025 | Otezla, Repatha, Otezla |
| Amarin Pharma, INC. | $506.17 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $468.88 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Astrazeneca Pharmaceuticals LP | $441.99 | 2019-2025 | Airsupra, Breztri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $430.21 | 2025 | Caplyta |
| Astellas Pharma US INC | $279.13 | 2019-2025 | Veozah |
| Pfizer INC. | $263.95 | 2020-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $175.80 | 2019-2024 | Xifaxan, Trulance |
| Merck Sharp & Dohme LLC | $171.66 | 2019-2021 | |
| Lilly USA, LLC | $165.32 | 2020-2025 | Mounjaro, Zepbound, Kisunla |
| Biohaven Pharmaceuticals, INC. | $162.94 | 2021 | |
| Mannkind Corporation | $152.78 | 2023-2024 | Afrezza |
| Intuity Medical INC | $122.56 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $107.35 | 2024-2025 | |
| Gilead Sciences, INC. | $102.64 | 2019 | |
| Exact Sciences Corporation | $69.64 | 2024-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $65.55 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $59.26 | 2021 | |
| Phadia US INC. | $48.31 | 2021-2023 | Immunocap |
| Renalytix Ai, INC. | $45.08 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Phathom Pharmaceuticals, INC. | $40.37 | 2024 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $36.66 | 2023 | |
| Genentech USA, INC. | $33.89 | 2019-2020 | |
| Glaxosmithkline, LLC. | $27.46 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $25.14 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $24.46 | 2022 | |
| Dexcom, INC. | $23.99 | 2025 | Dexcom G6 Transmitter |
| Shield Therapeutics INC | $23.04 | 2024 | |
| Axsome Therapeutics, INC. | $20.89 | 2022 | |
| Allergan, INC. | $18.33 | 2020 | |
| Janssen Pharmaceuticals, INC | $18.32 | 2023 | Xarelto |
| Hologic Sales and Service, LLC | $15.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Petelis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.